Address: P.O. Box 51706, CY-3508, Limassol, Cyprus (Europe)
Tel: (+357) 25553000
Remedica is based in Limassol, Cyprus and is the leading pharmaceutical company in the country. Remedica is dedicated to the development, production and sale of high quality generic pharmaceutical products. These fall into a wide range of therapeutic categories such as anticancer, antibiotics, analgesics, cardiovascular drugs, CNS agents, drugs for the GI tract, diuretics, antihistamines, antidiabetics, antiparkinsonian agents, hormones and synthetic substitutes, vitamins, cough medicines and expectorants, and many more. Remedica produces a variety of pharmaceutical dosage forms, including tablets, capsules, creams, ointments, aerosols, pessaries, suppositories, liquids, powders. The products of Remedica circulate in more than seventy countries worldwide through a selective network of representatives.
anticancer, antibiotics, analgesics, cardiovascular drugs, CNS agents, drugs for the GI tract, diuretics, antihistamines, antidiabetics, antiparkinsonian agents, hormones and synthetic substitutes, vitamins, cough medicines and expectorants
Michael Neoptolemou, managing director at Remedica, takes us through the evolution of one of the leading pharmaceutical companies in Cyprus and outlines their successful business model. Neoptolemou also highlights the…
How do you explain that despite the Bolar exemption, a high number of scientists, a very educated population, and Europe’s lowest tax rate, Cyprus has never been able to attract…
George Campanellas provides an overview of Invest Cyprus’ strategy for attracting foreign investment into Cyprus. He touches on sourcing interest from a wide range of sectors and highlights what makes…
With a population of just 1.2 million and a proportionately small pharmaceutical market by EU standards, Cyprus is often overlooked as a healthcare and life sciences investment destination. However, with…
In an exclusive interview, President Nicos Anastasiades outlines his public health priorities, the continuing importance of the pharmaceutical industry to Cyprus’s economy, and the nation’s attractiveness as an international investment…
Healthcare and life science industry advisory services head at KPMG Cyprus, Iacovos Ghalanos, discusses the challenge of implementing the National Health Insurance Scheme, pricing pressures and how their innovative services…
Cyprus is capitalizing on its well-established tourism infrastructure to stake a claim for itself as one of Europe’s premier medical tourism destinations. “I believe Cyprus can become a really important…
Varnavas Varnava, the founder and director of Biotronics, highlights the importance of diversification when operating in a small market, as well as discloses his future plans for the company and…
The Cyprus Health Insurance Organization (HIO) was established in 2001 under Law N.89(I)/2001 as a public legal entity with the mission to implement a General Healthcare System in Cyprus. As…
Philippos Patsalis, CEO and founder of NIPD Genetics, tells the story of the creation of Cyprus’s first ever biotech company and all its accomplishments after seven years of existence. He…
Vakis Frangos, managing director for commercial operations at Delorbis, walks us through the unique history of the company as one of the few local manufacturers in the island as well…
In a move to capitalize on a global market projected to exceed USD 60 billion by 2024, Cyprus has joined a growing number of European nations in legally permitting the…
Mario Sciberras, former general manager for Malta and Gibraltar became general manager for Cyprus, Malta, and Gibraltar in 2016. In this interview, he touches on themes of transparency, GSK’s positioning…
Christoforos Hadjikyprianou of the European University Cyprus, home to the island’s only state-of-the-art medical school, explains the institution’s unique value proposition and his vision for the future. Could you introduce…
See our Cookie Privacy Policy Here
